"growing threat of illegal medicines being advertised and sold online,"
"There's so much hype that the general public sees this medication more as a lifestyle or vanity product rather than a highly regulated pharmaceutical used for the clinical treatment of diabetes and obesity,"
Use of injectable weight-loss drugs has surged: 12% of the US population reported using such medications in the past year, more than double early-2024 levels. In the UK, 21% accessed an online or in-person pharmacy for weight-loss medication, and uptake in Germany has risen even when patients must self-fund. Regulators warn of a growing threat from illegal, counterfeit, and unapproved products, including retatrutide—which remains in clinical trials—and the banned substance sibutramine. Interpol reports weight-loss drugs now represent a growing share of counterfeit and unapproved medicines intercepted. Large seizures, including thousands of retatrutide pens, reflect criminal trafficking driven by demand and shortages.
Read at www.dw.com
Unable to calculate read time
Collection
[
|
...
]